Development and clinical application of an LC-MS-MS method for mescaline in urine

Journal of Analytical Toxicology

Volumn 32, Issue 3, 2008, Pages 227-231

  Björnstad, Kristian ^a   Helander, Anders ^a   Beck, Olof ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

AMPHETAMINE DERIVATIVE; BENZODIAZEPINE DERIVATIVE; CANNABIS; COCAINE; DEXTROPROPOXYPHENE; MESCALINE; MORPHINE; PSYCHEDELIC AGENT;

ADOLESCENT; ADULT; ARTICLE; CONTROLLED STUDY; DRUG SCREENING; DRUG STRUCTURE; DRUG URINE LEVEL; HUMAN; HUMAN TISSUE; LIQUID CHROMATOGRAPHY; MAJOR CLINICAL STUDY; REPRODUCIBILITY; SENSITIVITY AND SPECIFICITY; SOLID PHASE EXTRACTION; TANDEM MASS SPECTROMETRY; VOLUNTEER;

CACTACEAE;

EID: 41649110023     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/32.3.227     Document Type: Article

References (15)

1. J.G. Bruhn, P.A. De Smet, H.R. El-Seedi, and O. Beck. Mescaline use for 5700 years. Lancet 359: 1866 (2002).
2. C. Rätsch. The Encyclopedia of Psychoactive Plants. Park Street Press, Rochester, VT, 2005, pp 326-341.
3. R.E. Schultes and A. Hoffmann. Plants of the Gods - Origins of Hallucinogenic Use. Healing Arts Press, Rochester, VT, 1979.
4. A. Shulgin and A. Shulgin. PiHKAL - A Chemical Love Story. Transform Press, Berkeley, CA, 1991.
5. K.D. Charalampous, K.E.Walker, and J. Kinross-Wright. Metabolic fate of mescaline in man. Psychopharmacologia 9: 48-63 (1966).
6. H. Becker. Constituents of the cactus Lophophora williamsii. Pharm. Unserer Zeit. 14: 129-137 (1985).
7. J.L. Valentine and R. Middleton. GC-MS identification of sympathomimetic amine drugs in urine. J. Anal. Toxicol. 24: 211-222 (2000).
8. V. Habrdova, F.T. Peters, D.S. Theobald, and H.H. Maurer. Screening for and validated quantification of phenethylamine-type designer drugs and mescaline in human blood plasma by gas chromatography/mass spectrometry. J. Mass Spectrom. 40: 785-795 (2005).
9. H.H. Maurer. Current role of liquid chromatography-mass spectrometry in clinical and forensic toxicology. Anal. Bioanal. Chem. 388: 1315-1325 (2007).
10. J. Beyer, F.T. Peters, T. Kraemer, and H.H. Maurer. Detection and validated quantification of nine herbal phenalkylamines and methcathinone in human blood plasma by LC-MS-MS with electrospray ionization. J. Mass Spectrom. 42: 150-160 (2007).
11. H. Nordgren and O. Beck. Multicompetent screening for drugs of abuse. Ther. Drug. Monit. 26: 90-97 (2004).
12. B. Maralikova and W. Weinmann. Confirmatory analysis for drugs of abuse in plasma and urine by high-performance liquid chromatography-tandem mass spectrometry with respect to criteria for compound identification. J. Chromatogr. B 811: 21-30 (2004).
13. K.B. Nolte and R.E. Zumwalt. Fatal peyote ingestion associated with Mallory-Weiss lacerations. West J. Med. 170: 328 (1999).
14. P.C. Reynolds and E.J. Jindrich. A mescaline associated fatality. J. Anal. Toxicol. 9: 183-184 (1985).
15. J.L. Henry, J. Epley, and T.P. Rohrig. The analysis and distribution of mescaline in postmortem tissues. J. Anal. Toxicol. 27: 381-382 (2003).